文献速递系统性红斑狼疮

经皮耳迷走神经刺激减轻系统性红斑狼疮疼痛与疲劳的随机双盲假刺激对照预试验

Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
PubMed 文献 · Ann Rheum Dis · 2020-11-03

该随机双盲假刺激对照预试验纳入18例伴有肌肉骨骼疼痛(VAS≥4)的系统性红斑狼疮患者,按2:1随机接受经皮耳迷走神经刺激(taVNS)或假刺激4天。taVNS组疼痛和疲劳显著下降,临床显著疼痛缓解的OR=25(p=0.02),且疼痛与疲劳改善与累积电流相关,反应维持至第12天。

要点

  • taVNS可显著降低SLE患者疼痛与疲劳,临床显著疼痛缓解OR=25(p=0.02)。
  • PtGA、关节计数和PGA亦改善,疼痛与疲劳改善与累积电流相关。
  • 血浆P物质第5天较基线显著下降,其他神经肽与炎症介质无显著变化。

核心结论

  • taVNS显著降低SLE患者疼痛、疲劳和关节评分,需进一步研究该干预及其机制。

研究设计与样本

  • 随机双盲假刺激对照预试验,18例伴肌肉骨骼疼痛(10 cm VAS≥4)的SLE患者按2:1随机接受taVNS或假刺激4天。
  • 评估于基线、第5天和第12天进行,包括患者疼痛、疾病活动度(PtGA)和疲劳评估,以及盲法医师的压痛/肿胀关节计数和PGA。

主要发现

  • taVNS与假刺激均耐受良好;taVNS组疼痛和疲劳较假刺激组显著下降。
  • taVNS组出现临床显著疼痛缓解的可能性更高(OR=25,p=0.02)。
  • PtGA、关节计数和PGA亦改善;疼痛减轻和疲劳改善与累积电流相关。
  • 反应总体维持至第12天;taVNS后第5天血浆P物质较基线显著下降。
  • 其他神经肽、血清及全血刺激炎症介质和犬尿氨酸代谢物在第5天或第12天较基线无显著变化。

关键数值与推荐

  • 纳入标准:SLE患者,肌肉骨骼疼痛在10 cm视觉模拟量表上≥4。
  • 随机比例:taVNS与假刺激为2:1。
  • 刺激疗程:连续4天。
  • 临床显著疼痛缓解的比较:OR=25,p=0.02。

临床怎么用

  • taVNS可作为SLE伴肌肉骨骼疼痛患者减轻疼痛和疲劳的非侵入性干预选项。
  • 治疗反应与累积电流相关,提示刺激剂量可能影响疗效。
  • 疼痛与疲劳改善可维持至第12天,支持后续更大规模研究。

局限性

  • 本研究为预试验,样本量仅18例。
  • 研究为单中心、短期干预(4天)和短期随访(至第12天)。
  • 机制探索有限,仅P物质显著下降,其他炎症介质无显著变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Musculoskeletal pain and fatigue are common features in systemic lupus erythematosus (SLE). The cholinergic anti-inflammatory pathway is a physiological mechanism diminishing inflammation, engaged by stimulating the vagus nerve. We evaluated the effects of non-invasive vagus nerve stimulation in patients with SLE and with musculoskeletal pain. METHODS: 18 patients with SLE and with musculoskeletal pain ≥4 on a 10 cm Visual Analogue Scale were randomised (2:1) in this double-blind study to receive transcutaneous auricular vagus nerve stimulation (taVNS) or sham stimulation (SS) for 4 consecutive days. Evaluations at baseline, day 5 and day 12 included patient assessments of pain, disease activity (PtGA) and fatigue. Tender and swollen joint counts and the Physician Global Assessment (PGA) were completed by a physician blinded to the patient's therapy. Potential biomarkers were evaluated. RESULTS: taVNS and SS were well tolerated. Subjects receiving taVNS had a significant decrease in pain and fatigue compared with SS and were more likely (OR=25, p=0.02) to experience a clinically significant reduction in pain. PtGA, joint counts and PGA also improved. Pain reduction and improvement of fatigue correlated with the cumulative current received. In general, responses were maintained through day 12. Plasma levels of substance P were significantly reduced at day 5 compared with baseline following taVNS but other neuropeptides, serum and whole blood-stimulated inflammatory mediators, and kynurenine metabolites showed no significant change at days 5 or 12 compared with baseline. CONCLUSION: taVNS resulted in significantly reduced pain, fatigue and joint scores in SLE. Additional studies evaluating this intervention and its mechanisms are warranted.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Aranow C, Atish-Fregoso Y, Lesser M, et al. Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial. Ann Rheum Dis. 2020. PMID: 33144299. doi:10.1136/annrheumdis-2020-217872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。